Design, synthesis and biological evaluation of novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment of triple negative breast cancer by suppressing PI3K/AKT/mTOR pathway

Release time:2022-12-15|Hits:

Affiliation of Author(s):医学融合与实践中心

Journal:BIOORGANIC & MEDICINAL CHEMISTRY Journal

First Author:秦静

Document Code:82E4E0E42BED47D4A81BD9C8709A7F60

Volume:55

Number of Words:3500

Translation or Not:no

Date of Publication:2022-02-01